Predicting the clinical significance of red cell antibodies with in vitro cellular assays.
Garratty
G
G
American Red Cross Blood Services, Los Angeles-Orange Counties Region 90006.
D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D000920:Antibody-Dependent Cell Cytotoxicity; D001789:Blood Group Antigens / Q000276:immunology; D002470:Cell Survival; D002860:Chromium Radioisotopes; D003165:Complement System Proteins / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D004899:Erythroblastosis, Fetal / Q000097:blood; D004912:Erythrocytes / Q000276:immunology*; D006801:Humans; D007158:Immunologic Techniques; D007231:Infant, Newborn; D008264:Macrophages / Q000502:physiology; D009000:Monocytes / Q000502:physiology; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D012204:Rh-Hr Blood-Group System / Q000276:immunology; D012397:Rosette Formation
D000888:Antibodies, Anti-Idiotypic; D001789:Blood Group Antigens; D002860:Chromium Radioisotopes; D012204:Rh-Hr Blood-Group System; D003165:Complement System Proteins